[
  {
    "reportName": "Condensed Balance Sheet",
    "data": {
      "header": "Condensed Balance Sheet - USD $ in Thousands",
      "period": "Sep. 30, 2023",
      "data": {
        "Restricted cash and restricted cash equivalents": 63260,
        "Investment securities (includes available-for-sale securities of $486,091 and $195,438 at fair value with associated amortized cost of $486,999 and $203,418, as of September 30, 2023 and December 31, 2022, respectively)": 579738,
        "Loans held for sale, at fair value": 894073,
        "Loans held for investment (less allowance for credit losses on loans at amortized cost of $51,923 and $40,788, as of September 30, 2023 and December 31, 2022, respectively)": 361248,
        "Servicing rights": 142654,
        "Property, equipment and software": 201931,
        "Goodwill": 1393505,
        "Intangible assets": 387307,
        "Operating lease right-of-use assets": 93379,
        "Other assets (less allowance for credit losses of $1,581 and $2,785, as of September 30, 2023 and December 31, 2022, respectively)": 526538,
        "Total assets": 957333,
        "Interest-bearing deposits": 15607349,
        "Noninterest-bearing deposits": 64624,
        "Total deposits": 15671973,
        "Accounts payable, accruals and other liabilities": 1458,
        "Operating lease liabilities": 113361,
        "Debt": 619574,
        "Residual interests classified as debt": 10194,
        "Total liabilities": 22603391,
        "Redeemable preferred stock, $0.00 par value: 100,000,000 and 100,000,000 shares authorized; 3,234,000 and 3,234,000 shares issued and outstanding, as of September 30, 2023 and December 31, 2022, respectively": 320374,
        "Common stock": 95,
        "Additional paid-in capital": 6904869,
        "Accumulated other comprehensive income (loss)": 600,
        "Total permanent equity": 5053388,
        "Total liabilities, temporary equity and permanent equity": 27977153
      }
    },
    "periodOfReport": "2023-09-30",
    "dateFiled": "2023-11-08",
    "formType": "10-Q",
    "quarter": "Q3"
  },
  {
    "reportName": "Condensed Statement of Operations and Comprehensive Loss",
    "data": {
      "header": "Condensed Statement of Operations and Comprehensive Loss - USD $ in Thousands",
      "period": "3 Months Ended",
      "data": {
        "Securitizations": 1980,
        "Other": 26996,
        "Total interest income": 564270,
        "Securitizations and warehouses": 63847,
        "Deposits": 145563,
        "Corporate borrowings": 9784,
        "Total interest expense": 219307,
        "Net interest income": 344963,
        "Loan origination and sales": 81683,
        "Servicing": 8009,
        "Technology products and solutions": 81856,
        "Total noninterest income": 192246,
        "Total net revenue": 537209,
        "Technology and product development": 125698,
        "Sales and marketing": 186719,
        "Cost of operations": 98258,
        "General and administrative": 124457,
        "Goodwill impairment": 247174,
        "Provision for credit losses": 21831,
        "Total noninterest expense": 804137,
        "Income tax benefit (expense)": 244,
        "Unrealized gains (losses) on available-for-sale securities, net": 5616,
        "Foreign currency translation adjustments, net": 103,
        "Total other comprehensive income (loss)": 5719,
        "Weighted average common stock outstanding - basic (in shares)": 951183107,
        "Weighted average common stock outstanding - diluted (in shares)": 951183107
      }
    },
    "periodOfReport": "2023-09-30",
    "dateFiled": "2023-11-08",
    "formType": "10-Q",
    "quarter": "Q3"
  },
  {
    "reportName": "Condensed Statement of Cash Flow",
    "data": {
      "header": "Condensed Statement of Cash Flow - USD $ in Thousands",
      "period": "9 Months Ended",
      "data": {
        "Share-based compensation expense": 202109,
        "Depreciation and amortization": 147967,
        "Goodwill impairment": 247174,
        "Deferred debt issuance and discount expense": 15049,
        "Provision for credit losses": 42853,
        "Fair value changes in residual interests classified as debt": 414,
        "Fair value changes in securitization investments": 1067,
        "Other": 11635,
        "Servicing assets": 6210,
        "Other assets": 15052,
        "Accounts payable, accruals and other liabilities": 16051,
        "Proceeds from sales of available-for-sale investments": 265634,
        "Proceeds from maturities and paydowns of available-for-sale investments": 87463,
        "Proceeds from securitization investments": 101292,
        "Proceeds from non-securitization investments": 3163,
        "Purchases of non-securitization investments": 0,
        "Acquisition of businesses, net of cash acquired": 58540,
        "Net change in deposits": 8296657,
        "Net change in debt facilities": 902777,
        "Proceeds from other debt issuances": 339995,
        "Proceeds from stock option exercises": 1015,
        "Net cash provided by financing activities": 8906046,
        "Effect of exchange rates on cash and cash equivalents": 202,
        "Net increase in cash, cash equivalents, restricted cash and restricted cash equivalents": 1450715,
        "Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period": 1846302,
        "Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period": 3297017,
        "Cash and cash equivalents": 2813876,
        "Restricted cash and restricted cash equivalents": 483141,
        "Total cash, cash equivalents, restricted cash and restricted cash equivalents": 3297017,
        "Derecognition of securitization investments": 5325,
        "Loans held for investment received in acquisition": 0,
        "Available-for-sale securities received in acquisition": 0,
        "Deconsolidation of securitization and residual debt": 92914,
        "Deposits credited but not yet received in cash": 81116,
        "Share-based compensation capitalized related to internally-developed software": 22817
      }
    },
    "periodOfReport": "2023-09-30",
    "dateFiled": "2023-11-08",
    "formType": "10-Q",
    "quarter": "Q3"
  }
]